Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Olympus ( (JP:7733) ).
Olympus released its consolidated financial results for fiscal year 2026 and issued full-year guidance for fiscal 2027, outlining management’s current views and expectations for the business. The company emphasized that these results and projections are subject to various risks and uncertainties, underscoring that the materials are informational rather than promotional or advisory in nature and that future performance and product availability are not guaranteed.
The most recent analyst rating on (JP:7733) stock is a Hold with a Yen1700.00 price target. To see the full list of analyst forecasts on Olympus stock, see the JP:7733 Stock Forecast page.
More about Olympus
Olympus Corporation operates in the medical technology sector, focusing on endoscopy, surgical devices, and other healthcare solutions. The company targets global healthcare markets by providing advanced diagnostic and therapeutic equipment, positioning itself as a key player in minimally invasive medicine and related technologies.
Average Trading Volume: 6,650,062
Technical Sentiment Signal: Sell
Current Market Cap: Yen1730B
See more data about 7733 stock on TipRanks’ Stock Analysis page.